Research ArticleANTIBODIES

Enhancing FcγR-mediated antibody effector function during persistent viral infection

See allHide authors and affiliations

Science Immunology  21 Sep 2018:
Vol. 3, Issue 27, eaao3125
DOI: 10.1126/sciimmunol.aao3125

Article Information

vol. 3 no. 27

PubMed: 
Published By: 
History: 
  • Received July 6, 2017
  • Revision received May 28, 2018
  • Accepted August 1, 2018
  • .

Author Information

  1. Andreas Wieland1,*,
  2. Alice O. Kamphorst1,,
  3. Rajesh M. Valanparambil1,
  4. Jin-Hwan Han1,,
  5. Xiaojin Xu1,
  6. Biswa P. Choudhury2 and
  7. Rafi Ahmed1,*
  1. 1Emory Vaccine Center, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.
  2. 2Glycotechnology Core Resources, University of California at San Diego, La Jolla, CA 92093, USA.
  1. *Corresponding author. Email: awielan{at}emory.edu (A.W.); rahmed{at}emory.edu (R.A.)
  • Present address: Department of Oncological Sciences and Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

  • Present address: Merck Research Laboratories, Palo Alto, CA 94304, USA.

Altmetric

Article usage

Article usage: September 2018 to December 2019

AbstractFullPdf
Sep 201804931766
Oct 20189521833270
Nov 20182235123
Dec 20181432913
Jan 20193004219
Feb 20192042515
Mar 2019962620
Apr 2019664112
May 201983146
Jun 201939134
Jul 201942178
Aug 201956138
Sep 2019554330
Oct 2019210039
Nov 2019710619
Dec 20190142

Navigate This Article